MHRA Safety Guidelines for Omeprazole During Pregnancy
Official MHRA Position on Omeprazole Pregnancy Safety
The MHRA (Medicines and Healthcare products Regulatory Agency) classifies omeprazole delayed release capsules under pregnancy category B, indicating no proven risk in humans. Current evidence suggests omeprazole may be used during pregnancy when the clinical benefit outweighs potential risks, particularly for managing severe gastro-oesophageal reflux disease (GORD) that significantly impacts quality of life.
Recommended Dosage During Pregnancy
Healthcare professionals typically prescribe omeprazole 20mg once daily as the standard dose for pregnant women experiencing acid reflux symptoms. The MHRA emphasises using the minimum effective dose for the shortest duration necessary. Some women may require omeprazole 40mg daily for severe symptoms, though this should only be prescribed under medical supervision. EverydayMeds stocks both Omeprazole 20mg Capsules and Losec MUPS 20mg tablets for convenient access to treatment.
Alternative Treatments Available
For women preferring alternatives to omeprazole during early pregnancy, several options exist. Famotidine tablets represent an H2 receptor antagonist with extensive pregnancy safety data. Lansoprazole 15mg capsules offer another PPI option with similar efficacy profiles. Some healthcare providers recommend trying famotidine first, progressing to omeprazole if symptoms persist. EverydayMeds provides access to these alternative treatments through our online consultation service.
When to Seek Medical Advice
Pregnant women should consult healthcare professionals before starting omeprazole delayed release treatment. Immediate medical attention is required if experiencing severe abdominal pain, difficulty swallowing, or persistent vomiting alongside acid reflux symptoms. Regular monitoring ensures treatment remains appropriate throughout different pregnancy stages, with dosage adjustments made as necessary for optimal maternal and foetal wellbeing.
